Carvedilol Drug Profile

What is Carvedilol?

Carvedilol is a beta-blocker medication that also has alpha-blocking properties, making it a unique dual-action cardiovascular drug. It belongs to the class of medications known as non-selective beta-blockers with vasodilating activity. Carvedilol is primarily prescribed to treat high blood pressure, heart failure, and to improve survival after heart attacks.

Uses

Carvedilol is approved for several cardiovascular conditions:

• High blood pressure (hypertension): Used alone or in combination with other medications to lower blood pressure and reduce the risk of stroke, heart attack, and kidney problems
• Chronic heart failure: Helps improve heart function and reduces symptoms in patients with mild to severe heart failure
• Left ventricular dysfunction after heart attack: Prescribed to improve survival and reduce the risk of further cardiovascular events following a myocardial infarction
• Angina prevention: May be used to reduce chest pain episodes in patients with coronary artery disease
• Cardiomyopathy: Sometimes prescribed for certain types of enlarged or weakened heart muscle conditions

How it works

Carvedilol works by blocking both beta-adrenergic receptors in the heart and alpha-1 adrenergic receptors in blood vessels. By blocking beta receptors, it slows the heart rate and reduces the force of heart contractions, decreasing the heart’s workload and oxygen demand. The alpha-blocking action causes blood vessels to relax and widen, which helps lower blood pressure and improves blood flow throughout the body.

Side effects

Common side effects include:

Submit Your Paper

• Dizziness or lightheadedness
• Fatigue or weakness
• Low blood pressure
• Slow heart rate
• Diarrhea
• Weight gain
• Shortness of breath
• Cold hands and feet

Serious side effects that require immediate medical attention:

• Severe allergic reactions with swelling of face, lips, or throat
• Worsening heart failure symptoms (severe shortness of breath, rapid weight gain)
• Severe low blood pressure with fainting
• Severe slow heart rate or heart rhythm problems
• Liver problems (yellowing of skin or eyes, dark urine)

Warnings and precautions

• Abrupt discontinuation: Never stop carvedilol suddenly as this can cause dangerous rebound effects including heart attack, severe high blood pressure, or irregular heartbeat
• Respiratory conditions: Use with extreme caution in patients with asthma, COPD, or other breathing problems, as beta-blockers can worsen these conditions
• Diabetes: May mask signs of low blood sugar and can affect blood glucose control
• Pregnancy and breastfeeding: Should be used only when benefits outweigh risks; can cross into breast milk
• Liver or kidney disease: Dosage adjustments may be necessary, and regular monitoring is required for patients with impaired liver function

Interactions

• Calcium channel blockers: Can increase the risk of dangerously low blood pressure and slow heart rate when combined
• Insulin and diabetes medications: May enhance blood sugar-lowering effects and mask symptoms of hypoglycemia
• Digoxin: Carvedilol can increase digoxin levels in the blood, potentially leading to toxicity
• Blood pressure medications: Combined use with other antihypertensive drugs can cause excessive blood pressure reduction
• NSAIDs (ibuprofen, naproxen): May reduce the blood pressure-lowering effectiveness of carvedilol
• Rifampin: Can significantly reduce carvedilol levels and effectiveness
• Cimetidine: May increase carvedilol blood levels and enhance its effects
• MAO inhibitors: Can cause dangerous interactions affecting blood pressure and heart rate

Check interactions with the GMJ Interaction Checker

Dosage

Carvedilol dosing varies significantly based on the condition being treated and individual patient factors. For hypertension, the typical starting dose is 6.25 mg twice daily, which may be gradually increased to a maximum of 25 mg twice daily. For heart failure, treatment usually begins with 3.125 mg twice daily and can be increased up to 25-50 mg twice daily depending on patient tolerance and body weight. For post-heart attack treatment, the starting dose is typically 6.25 mg twice daily, increased gradually to a target of 25 mg twice daily. All dose adjustments should be made gradually over several weeks under medical supervision. Your healthcare provider will determine the appropriate dosage based on your specific condition, response to treatment, and other medications you may be taking.

Sources: FDA DailyMed drug labels (public domain), BNF, WHO Essential Medicines List. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting or stopping any medication.

This work is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). You are free to share and adapt this content with attribution to GMJ News (news.gmj.ge).